Global Medical REIT downgraded by Robert W. Baird with a new price target
$GMRE
Real Estate Investment Trusts
Real Estate
Robert W. Baird downgraded Global Medical REIT from Outperform to Neutral and set a new price target of $9.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/3/2025 | $9.00 | Neutral | B. Riley Securities |
| 10/18/2024 | $11.75 | Buy | Berenberg |
| 9/19/2024 | $12.00 | Buy | Alliance Global Partners |
| 10/10/2022 | $9.00 | Outperform → Neutral | Robert W. Baird |
| 10/6/2022 | $13.00 → $9.00 | Outperform → Market Perform | BMO Capital Markets |
| 7/7/2022 | Mkt Perform | JMP Securities | |
| 1/13/2022 | Overweight → Sector Weight | Keybanc | |
| 9/20/2021 | $17.00 | Overweight | Keybanc |
8-K - Global Medical REIT Inc. (0001533615) (Filer)
SCHEDULE 13G - Global Medical REIT Inc. (0001533615) (Subject)
8-K - Global Medical REIT Inc. (0001533615) (Filer)
B. Riley Securities resumed coverage of Global Medical REIT with a rating of Neutral and set a new price target of $9.00
Berenberg initiated coverage of Global Medical REIT with a rating of Buy and set a new price target of $11.75
Alliance Global Partners initiated coverage of Global Medical REIT with a rating of Buy and set a new price target of $12.00